SepsisFrom March 2019, A World of (Bladder) Hurt
To discuss the epidemiology and identification of sepsis, identify areas of increased focus in sepsis management, discuss three recent large trials about early goal-directed therapy, and delineate how we may improve our processes of care. •18min 56Tom Robertson, MD, Mizuho Morrison, DO, and Nirav Shah, MD
Pharmacologic Treatment of Alcohol Use DisorderFrom March 2019, A World of (Bladder) Hurt
How much do we really know about the pharmacologic treatment of alcohol use disorder? After this segment with Dr. Michael Baca-Atlas and our own Neda Frayha, the answer will be, a whole lot. •16min 31Michael Baca Atlas, MD and Neda Frayha, MD
Aspirin: The Latest LiteratureFrom March 2019, A World of (Bladder) Hurt
What is the deal with aspirin for primary prevention of cardiovascular disease? In this segment, Tom and Steve break down some of the most recent, headline-grabbing articles on this exact subject.10min 27Steve Biederman, MD and Tom Robertson, MD
Alcohol Use Disorder: Emerging TherapiesFrom March 2019, A World of (Bladder) Hurt
How much do we really know about the pharmacologic treatment of alcohol use disorder? After this segment with Dr. Michael Baca-Atlas and our own Neda Frayha, the answer will be, a whole lot.9min 10Michael Baca Atlas, MD and Neda Frayha, MD
DOAC ReversalFrom February 2019, Into Thin Hair
Continuing the recent discussion between Matt DeClerck and Dr. Tom Deloughery on the direct oral anticoagulants (DOACs), this month we bring you a segment on reversing these DOACs with Matt, Neda, and Dr. Tarlan Hedayati. What are the agents currently on the market, including the newest kid on the …20min 52Tarlan Hedayati, MD, Neda Frayha, MD, and Matthieu DeClerck, MD
Starting OCPsFrom February 2019, Into Thin Hair
Listeners have been asking for lots of segments on oral contraceptive pills, especially on how to choose an agent when prescribing OCPs to a patient for the first time. In this segment, Molly and Neda build on our Things I Do But Should I duo’s recent OCP myth-busting and go through a systematic …18min 5Molly Heublein, MD and Neda Frayha, MD
PPI DeprescribingFrom January 2019, Hello, New Year! Bye Bye, PPIs?
When a listener asked us about the adverse effects of proton pump inhibitors and whether (and how) we should deprescribe these drugs, Neda and Rob jumped all over it. In this segment, they’ll review the major categories of adverse effects described in the literature and figure out what it all means.14min 59Neda Frayha, MD and Rob Orman, MD
TIDBSI: OCP MythsFrom January 2019, Hello, New Year! Bye Bye, PPIs?
In this Things I Do But Should I segment, Adrien and Vanessa tackle some commonly held misconceptions about oral contraceptive pills. It’s one segment of an ongoing series on OCPs, inspired by questions from our listeners.17min 41Vanessa Gervais, MD and Adrien Selim, MD
Gastroesophageal Reflux DiseaseFrom January 2019, Hello, New Year! Bye Bye, PPIs?
Miz and Jenny discuss current diagnosis, workup and management of GERD. Jenny highlights the step-up approach to treatment when lifestyle modifications alone are insufficient.19min 28Mizuho Morrison, DO and Jenny Beck-Esmay, MD
ACE vs ARBFrom December 2018, Clots and OCP's
Andrew Buelt has often wondered why clinicians are so quick to prescribe ACE inhibitors over ARBs. In this segment, he looks at the literature to investigate whether or not this is actual best practice.10min 8Andrew Buelt, DO
Menopause Treatment OptionsFrom November 2018, Those Clots are So Superficial
A listener asked for a review of menopause treatment options, especially given the controversial findings of the Women’s Health Initiative. So, in this segment, Drs. Molly Heublein and Neda Frayha discuss an evidence-based approach to the treatment of menopause symptoms.21min 58Molly Heublein, MD and Neda Frayha, MD
Things I Do But Should I: OCPs and AcneFrom November 2018, Those Clots are So Superficial
When a patient needs an oral contraceptive pill AND happens to have acne, which pill should we prescribe? Are any particular OCPs better than others? In this installment of Things I Do But Should I, Drs. Adrien Selim and Vanessa Gervais walk us through the OCP management of contraception and acne.8min 22Adrien Selim, MD and Vanessa Gervais, MD
Anticoagulation with the DOACsFrom October 2018, My Pancreas is Necrosing!
It’s time for Hematology Rounds with Dr. Tom DeLoughery! In this segment, he and our own Matt DeClerck review the indications for and potential benefits and pitfalls of the direct oral anticoagulants (DOACs).31min 9Tom Deloughery, MD and Matthieu DeClerck, MD
Fluoroquinolones: Risks to Patients and ProvidersFrom October 2018, My Pancreas is Necrosing!
While widely prescribed, fluoroquinolones have been associated with a large number of adverse events and are the focus of multiple lawsuits against providers. • Currently there are FDA warnings regarding quinolone use and the risk of tendinitis, tendon rupture and peripheral neuropathy. More …11min 30Matthew DeLaney, MD, FACEP, FAAEM
New C Diff Infection GuidelinesFrom September 2018, Retrieve Those Filters
The new IDSA/SHEA practice guidelines on Clostridium difficile infection have a few changes from what we’re used to, mostly about the diagnostic algorithm and first-line treatment options. In this segment, Drs. Devang Patel and Neda Frayha review the new guidelines and how they impact our clinical …20minDevang Patel, MD and Neda Frayha, MD
Hyperemesis GravidarumFrom September 2018, Retrieve Those Filters
Miz and Jenny discuss diagnosis and management of hyperemesis gravidarum. Given recent concerns raised about the safety profile for Ondansetron • in both maternal and fetal health, Miz and Jenny review the most recent ACOG guidelines for treatment regimens as well as referral indications.20min 26Jenny Beck-Esmay, MD and Mizuho Morrison, DO
Is Aspirin Dead in A-Fib?From July 2018, All Risk, No Reward
In this PC RAP family reunion, Rob Orman and Neda Frayha discuss the latest evidence on the use of aspirin in low-risk a-fib (CHA2DS2-VASc score of 0 or 1).12min 14Neda Frayha, MD and Rob Orman, MD
Paper Chase #4 | Opioid vs Non Opioid Analgesia for Acute Extremity PainFrom May 2018, The Buzz That Won't Quit
For patients with acute extremity pain in the ED, there were no differences in pain reduction at 2 hours among single-dose treatment with ibuprofen and acetaminophen or with 3 different opioid and acetaminophen combination.4min 16Andrew Buelt, DO and Joe Weatherly, DO
SuboxoneFrom April 2018, Will You Be My Facebook Friend?
Adrien and Eric discuss the potential role of naloxone/buprenorphine (Suboxone) in helping patients manage opioid dependence. They review its pharmacology, indications, contraindications, administrations and potential pitfalls.20min 22Adrien Selim, MD and Eric Contant, MD
Lifestyle and Diabetes - Part 2From April 2018, Will You Be My Facebook Friend?
In part 2 of this segment on lifestyle and diabetes,Neil and Heidi review yet more evidence pointing toward the effectiveness of weight management and exercise in preventing and managing DM2. As a bonus, Neil concludes his story of how exercise has changed his life and health.17min 43Heidi James, MD and Neil Skolnik, MD
‹ PreviousNext ›